Authors: | Roth, B. J.; Bajorin, D. F. |
Article Title: | Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world |
Keywords: | clinical trial; cisplatin; doxorubicin; fluorouracil; advanced cancer; cancer combination chemotherapy; dose response; antineoplastic agents; alpha interferon; gemcitabine; paclitaxel; methotrexate; neoplasm staging; carboplatin; metastasis; liver toxicity; nephrotoxicity; phase 2 clinical trial; antimetabolites, antineoplastic; blood toxicity; mucosa inflammation; nausea; vomiting; antineoplastic combined chemotherapy protocols; granulocyte macrophage colony stimulating factor; calcitriol; pyrimidines; ifosfamide; vinblastine; docetaxel; fever; rash; drug mechanism; mitoxantrone; urinary diversion; epirubicin; phase 3 clinical trial; bladder neoplasms; phase 1 clinical trial; drug half life; bladder carcinoma; deoxycytidine; granulocyte colony stimulating factor; hearing loss; intravenous drug administration; hypocalcemia; oral drug administration; intramuscular drug administration; gallium; trimetrexate; pirarubicin; piritrexim; anthraquinone; optic nerve disease; gallium nitrate; human; priority journal; article |
Journal Title: | Journal of Urology |
Volume: | 153 |
Issue: | 3 Suppl. |
ISSN: | 0022-5347 |
Publisher: | Elsevier Science, Inc. |
Date Published: | 1995-03-01 |
Start Page: | 894 |
End Page: | 900 |
Language: | English |
DOI: | 10.1016/s0022-5347(01)67598-0 |
PUBMED: | 7853569 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Review -- Export Date: 28 August 2018 -- Source: Scopus |